InflaRx N.V. (IFRX)
$1.60+4.58%Close
SELLCRISIS · day 12
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $116M
- Beta
- 2.61
- P/E (TTM)
- -2.87
- Short % float
- 22.28%
- Days to cover
- 26.6
- SI change
- +2.1%
- 1W
- -6.98%
- 1M
- -21.95%
- vs SPY 1W
- -8.14%
- vs SPY 1M
- -24.94%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on IFRX?
- LOPJLB’s latest quantitative signal on InflaRx N.V. (IFRX) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is IFRX in?
- InflaRx N.V. (IFRX) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does InflaRx N.V. (IFRX) do?
- InflaRx N.V. is a clinical-stage biopharmaceutical firm dedicated to discovering and developing novel inhibitors leveraging C5a technology, primarily operating in Germany and the United States. The company's focus on C5a stems from its critical role as an inflammatory mediator implicated in the progression of various autoimmune and inflammatory diseases. Its primary product candidate, vilobelim…